The case of proband 56‐1 highlights a dilemma for future therapeutic intervention especially in view of the current achromatopsia CNGA3 gene therapy trials [NCT 02610582 (Reichel et al., 2017), 03278873, 03758404, and 02935517]. Here, CNGA3 is linked to achromatopsia.